West Pharmaceutical Services Restructuring Reserve Settled Without Cash2 remained flat by 0.0% to $900.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.5%, from $800.00K to $900.00K.
An increase suggests the company is accounting for future restructuring costs without immediate cash impact, potentially signaling efficiency initiatives.
This metric captures the portion of restructuring expenses that were recognized in the income statement but did not resu...
Varies significantly based on the company's current phase of operational transformation or cost-cutting programs.
other_restructuring_reserve_settled_without_cash2| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $3.83M | $3.83M | $3.83M | $3.83M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $800.00K | $800.00K | $900.00K | $900.00K |
| QoQ Change | — | — | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | — | — | — | — | — | +0.0% | +12.5% | +0.0% |
| YoY Change | — | — | — | — | — | — | — | -100.0% | -100.0% | -100.0% | -100.0% | — | — | — | — | — | — | — | +12.5% |